Prodrugs of betulinic acid derivatives for the treatment of cancer and HIV

Details for Australian Patent Application No. 2001284946 (hide)

Owner The Board of Trustees of the University of Illinois Advanced Life Sciences Inc.

Inventors Goldsmith, Miriam Elaine; Pezzuto, John M.; Xu, Ze-Qi; Kosmeder II, Jerome W.; Zhou, Nian En

Agent Spruson & Ferguson

Pub. Number AU-B-2001284946

PCT Pub. Number WO02/16395

Priority 60226536 18.08.00 US

Filing date 15 August 2001

Wipo publication date 4 March 2002

Acceptance publication date 1 February 2007

International Classifications

C07J 63/00 (2006.01) Steroids in which the cyclopenta[a]hydrophenanthrene skeleton has been modified by expansion of only one ring by one or two atoms

A61P 31/18 (2006.01) Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

A61P 35/00 (2006.01) Antineoplastic agents

Event Publications

22 January 2004 Amendment Made

  The nature of the amendment is: Add a co-inventor: Goldsmith, Miriam Elaine.

1 February 2007 Application Accepted

  Published as AU-B-2001284946

31 May 2007 Standard Patent Sealed

11 March 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2001284947

2001284945